The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19
Biospace,
The life science industry hasn’t hung up its lab coat and safety goggles just yet.
The life science industry hasn’t hung up its lab coat and safety goggles just yet.
- Preclinical data presented at ESMO demonstrates activity of the camelid TriKE in B7H3 positive and HER2+ solid tumor cancer…
BEVERLY HILLS, Calif., Sept. 20, 2021 /PRNewswire/ -- GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno…
BEVERLY HILLS, Calif., Sept. 20, 2021 /PRNewswire/ -- GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno…